Lumida
/AIRS
⌘K
AirSculpt Technologies Inc

AirSculpt Technologies Inc

AIRS
$2.42USD+0.83%+0.02 today

MARKET CAP

174.5M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2
$12

AI Summary

Stalk
StalkMedium

In Stage 2 Advancing, AIRS retains a medium-term bullish bias underpinned by higher highs/lows and support at the rising 50 DMA, but short-term timing is neutral as price pulls back into the 9/21/50 EMA zone. Execution should be deferred around this support range, seeking evidence of acceptance before committing. Primary risk is a decisive break below the 50 DMA and prior higher-low, which would invalidate the bullish outlook.

  • Pursuing GLP-1 market, aiming $100M+ revenue from post-treatment aesthetics
  • Same-center cases up 21pp YoY, stabilizing core body-contouring revenue
  • Earnings yield at -1.94% indicates inability to generate shareholder returns
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$133.3M$168.8M$195.9M$180.3M$151.8M
YoY %+26.6%+16.1%-7.9%-15.8%
P / Sales7.2x1.2x2.1x1.7x0.8x
EV / Sales7.9x1.9x2.6x2.4x1.4x
Gross Profit, Adj.$88.8M$106.0M$122.1M$109.2M$90.1M
YoY %+19.4%+15.2%-10.6%-17.5%
Margin %66.6%62.8%62.3%60.5%59.4%
EV / Gross Profit11.8x3.1x4.2x3.9x2.3x
EBITDA, Adj.$23.0M$4.6M$19.8M$10.3M$7.9M
YoY %-80.1%+330.1%-47.8%-23.0%
Margin %17.3%2.7%10.1%5.7%5.2%
EV / EBITDA45.5x71.2x26.2x41.3x26.5x
EBIT$15.8M$-3.5M$9.7M$-1.6M$-9.4M
YoY %-122.0%+380.5%-116.3%-494.3%
Margin %11.8%-2.1%5.0%-0.9%-6.2%
EV / EBIT66.5x-94.3x53.3x-269.0x-22.4x
Net Income$-393,000$-14.7M$-4.2M$-8.0M$-11.7M
YoY %-3635.1%+71.1%-89.1%-45.5%
Net Margin-0.3%-8.7%-2.2%-4.4%-7.7%
EPS (GAAP)-$0.01-$0.26-$0.08-$0.14-$0.19
YoY %-2500.0%+69.2%-75.0%-35.7%